Continuous glucose monitoring · Huzhou, since 2009
A glucose reading every 3 minutes, from a sensor you barely feel
MeiQi Medical designs and builds the RGMS-3O continuous glucose monitoring system: a 14-day sensor on a 0.12 mm microneedle, a transmitter and applicator that last 3 years, and the MQ CGM app.
Illustration, not a photograph. The actual product appearance prevails.
Since 2009
Making CGM systems in Huzhou
14 days
Wear time per sensor
7.74%
MARD accuracy
20 million
Sensor sets a year, capacity
The product
RGMS-3O, our third generation
Four parts work together. Only the sensor is single use.
GS-3O
Disposable sensor, 14 days on the upper arm
TS-3O
Transmitter, reusable for 3 years
AT-3O
One-press applicator, reusable for 3 years
MQ CGM
App for iOS and Android, seven languages
Technology
Built on our own sensor and algorithm patents
A 0.12 mm microneedle
3.5 mm long. Our data puts the wound area more than 90% smaller than comparable sensors.
Two electrodes, factory calibrated
A two-electrode sensor and our patented reference offset calibration algorithm, so users skip fingerstick calibration.
Hardware that stays
The transmitter and applicator are reused for 3 years, so each 14-day period costs one sensor.
Manufacturing
Automated cleanroom lines in Huzhou
Capacity for 20 million sensor sets a year, run under an ISO 13485:2016 quality system certified by TUV Rheinland.
ISO 13485 · SX 2112917-1
CE
Building CGM systems since 2009
Our story2009
MeiQi founded in Huzhou
2013
First-generation CGM launched in China
2017
Second-generation CGM launched
2025
Global sales partnership with Xinmei Medical
Questions about the RGMS-3O?
Sales, distribution and private label for the RGMS-3O are handled by our exclusive global partner, Xinmei Medical. Your message goes straight to their team.